Back to Browse Journals » International Journal of Nanomedicine » Volume 7
Controlled synthesis and characterization of hollow flower-like silver nanostructures
Authors Eid KAM, Azzazy HME
Received 7 October 2011
Accepted for publication 5 November 2011
Published 21 March 2012 Volume 2012:7 Pages 1543—1550
DOI https://doi.org/10.2147/IJN.S26524
Review by Single-blind
Peer reviewer comments 2
Kamel AM Eid, Hassan ME Azzazy
Novel Diagnostics and Therapeutics Group, Yousef Jameel Science and Technology Research Center, School of Sciences and Engineering, The American University in Cairo, New Cairo, Egypt
Background: The synthesis of anisotropic silver nanoparticles is a time-consuming process and involves the use of expensive toxic chemicals and specialized laboratory equipment. The presence of toxic chemicals in the prepared anisotropic silver nanostructures hindered their medical application. The authors have developed a fast and inexpensive method for the synthesis of three-dimensional hollow flower-like silver nanostructures without the use of toxic chemicals.
Methods: In this method, silver nitrate was reduced using dextrose in presence of trisodium citrate as a capping agent. Sodium hydroxide was added to enhance reduction efficacy of dextrose and reduce time of synthesis. The effects of all four agents on the shape and size of silver nanostructures were investigated.
Results: Robust hollow flower-like silver nanostructures were successfully synthesized and ranged in size from 0.2 µm to 5.0 µm with surface area between 25–240 m2/g. Changing the concentration of silver nitrate, dextrose, sodium hydroxide, and trisodium citrate affected the size and shape of the synthesized structures, while changing temperature had no effect.
Conclusion: The proposed method is simple, safe, and allows controlled synthesis of anisotropic silver nanostructures, which may represent promising tools as effective antimicrobial agents and for in vitro diagnostics. The synthesized hollow nanostructures may be used for enhanced drug encapsulation and sustained release.
Keywords: silver nanoparticles, 3D hollow, flower-like, green synthesis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Readers of this article also read:
Monitoring cancer stem cells: insights into clinical oncology
Lin SC, Xu YC, Gan ZH, Han K, Hu HY, Yao Y, Huang MZ, Min DL
OncoTargets and Therapy 2016, 9:731-740
Published Date: 11 February 2016
Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials
Van Heertum RL, Scarimbolo R, Ford R, Berdougo E, O’Neal M
Drug Design, Development and Therapy 2015, 9:5215-5223
Published Date: 11 September 2015
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
Aprile G, Leone F, Giampieri R, Casagrande M, Marino D, Faloppi L, Cascinu S, Fasola G, Scartozzi M
OncoTargets and Therapy 2015, 8:1149-1156
Published Date: 22 May 2015
Brachytherapy in the treatment of cervical cancer: a review
Banerjee R, Kamrava M
International Journal of Women's Health 2014, 6:555-564
Published Date: 28 May 2014
Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles
Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM
International Journal of Nanomedicine 2014, 9:1883-1889
Published Date: 16 April 2014
Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
Brueseke TJ, Tewari KS
Clinical Pharmacology: Advances and Applications 2013, 5:13-19
Published Date: 23 May 2013
Palliative care for adolescents and young adults with cancer
Rosenberg AR, Wolfe J
Clinical Oncology in Adolescents and Young Adults 2013, 3:41-48
Published Date: 24 March 2013
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
Yee AJ, Raje NS
Clinical Interventions in Aging 2012, 7:331-338
Published Date: 3 September 2012
Palliative nursing care for children and adolescents with cancer
Foster TL, Bell CJ, McDonald CF, Harris JS, Gilmer MJ
Nursing: Research and Reviews 2012, 2:17-25
Published Date: 15 June 2012
Multidisciplinary care in pediatric oncology
Cantrell MA, Ruble K
Journal of Multidisciplinary Healthcare 2011, 4:171-181
Published Date: 30 May 2011
